ASMB
ASSEMBLY BIOSCIENCES, INC.
-0.08 (-0.31%)25.40USD142K成交股數517M市值21.0本益比(近四季)6.9股價營收比+38.9%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 13.4M+42% | 8.2M+12% | 10.8M+58% | 9.6M+13% | 9.4M+63% | 7.4M | 6.8M | 8.5M | 5.8M | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 14.9M | 14.9M | 16.6M | 16.1M | 14.9M | 14.3M | 13.5M | 16.3M | 11.9M | 10.8M | 12.5M | 14.5M |
| 銷售管理費用 | 4.8M | 4.7M | 5.1M | 4.6M | 4.5M | 4.6M | 4.3M | 4.5M | 4.6M | 4.2M | 5.0M | 5.0M |
| 營業利益 | −6.3M-36% | −11.4M-1% | −10.9M-1% | −11.1M-9% | −9.9M-7% | −11.5M-23% | −11.0M-37% | −12.2M-38% | −10.7M | −15.0M | −17.5M | −19.6M |
| 營業利益率 | -47.4% | -138.4% | -100.9% | -115.2% | -105.5% | -156.7% | -160.1% | -143.0% | -185.5% | – | – | – |
| 稅後淨利 | −3.9M-56% | −9.1M-12% | −9.2M-4% | −10.2M-9% | −8.8M-3% | −10.3M-28% | −9.6M-43% | −11.2M-41% | −9.1M | −14.4M | −16.9M | −19.0M |
| 淨利率 | -28.8% | -110.5% | -85.2% | -105.9% | -93.6% | -140.5% | -140.4% | -130.7% | -156.9% | – | – | – |
| 稀釋 EPS | -0.20-83% | -0.54-65% | -0.72-52% | -1.33-33% | -1.17-30% | -1.54-53% | -1.51-61% | -1.98-56% | -1.66 | -3.29 | -3.88 | -4.46 |
| 稀釋股數 | 18.9M | 16.9M | 12.7M | 7.7M | 7.5M | 6.0M | 6.4M | 5.6M | 5.5M | 4.4M | 4.4M | 4.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 32.3M | 31.1M | 22.5M | 24.0M | 23.4M | 38.3M | 28.5M | 19.2M | 18.7M | 26.7M | 21.6M | 43.5M |
| 應收帳款 | 822K | 451K | 912K | – | – | 0 | 0 | 0 | 43K | 0 | 342K | 717K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 331M | 236M | 240M | 80.8M | 99.0M | 119M | 100M | 115M | 120M | 51.6M | 66.6M | 83.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 25.2M | 36.9M | 57.3M | 62.7M | 71.9M | 85.8M | 74.3M | 80.6M | 87.3M | 9.9M | 11.6M | 12.8M |
| 股東權益 | 306M | 199M | 183M | 18.1M | 27.1M | 33.4M | 26.0M | 34.7M | 32.6M | 41.7M | 54.9M | 70.3M |
| 負債比 | 7.6% | 15.7% | 23.9% | 77.6% | 72.6% | 72.0% | 74.1% | 69.9% | 72.8% | 19.2% | 17.5% | 15.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.1M | – | – | −23.4M+28% | – | – | – | −18.4M | – | – | −23.4M |
| 資本支出 | – | 19K | – | – | 0 | – | – | – | 14K | – | – | 0 |
| 自由現金流 | – | −22.1M | – | – | −23.4M+28% | – | – | – | −18.4M | – | – | −23.4M |
| 折舊攤銷 | – | 26K | – | – | 33K | – | – | – | 32K | – | – | 124K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -269.3% | – | – | -248.8% | – | – | – | -317.7% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 72.3M | +153.5% | −6.1M | -8.5% | -0.55 | −41.2M |
| FY2024 | 28.5M | +298.2% | −40.2M | -140.9% | -6.69 | −51.1M |
| FY2023 | 7.2M | – | −61.2M | -854.8% | -13.38 | 22.5M |
| FY2022 | 0 | -100.0% | −93.1M | –% | -23.08 | −84.6M |
| FY2021 | 6.3M | -92.1% | −130M | -2,076.4% | -3.00 | −96.5M |
| FY2020 | 79.1M | +395.6% | −62.2M | -78.6% | -1.75 | −63.4M |
| FY2019 | 16.0M | +7.8% | −97.6M | -611.6% | -3.72 | −85.6M |
| FY2018 | 14.8M | – | −90.8M | -613.0% | -3.98 | −65.3M |